Corvus Pharmaceuticals Inc (CRVS)
1.72
+0.11
(+6.83%)
USD |
NASDAQ |
May 02, 16:00
1.72
0.00 (0.00%)
After-Hours: 20:00
Corvus Pharmaceuticals 1 Year Total Returns (Daily): 45.04% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | 45.04% |
| April 30, 2024 | 43.52% |
| April 29, 2024 | 46.30% |
| April 26, 2024 | 41.46% |
| April 25, 2024 | 46.53% |
| April 24, 2024 | 51.00% |
| April 23, 2024 | 44.34% |
| April 22, 2024 | 35.85% |
| April 19, 2024 | 28.44% |
| April 18, 2024 | 31.78% |
| April 17, 2024 | 22.52% |
| April 16, 2024 | 41.35% |
| April 15, 2024 | 41.35% |
| April 12, 2024 | 43.66% |
| April 11, 2024 | 25.81% |
| April 10, 2024 | 20.80% |
| April 09, 2024 | 50.93% |
| April 08, 2024 | 58.33% |
| April 05, 2024 | 75.42% |
| April 04, 2024 | 56.48% |
| April 03, 2024 | 75.86% |
| April 02, 2024 | 104.4% |
| April 01, 2024 | 104.4% |
| March 28, 2024 | 174.6% |
| March 27, 2024 | 175.4% |
| Date | Value |
|---|---|
| March 26, 2024 | 158.9% |
| March 25, 2024 | 158.9% |
| March 22, 2024 | 153.9% |
| March 21, 2024 | 168.6% |
| March 20, 2024 | 170.0% |
| March 19, 2024 | 166.6% |
| March 18, 2024 | 158.5% |
| March 15, 2024 | 163.9% |
| March 14, 2024 | 175.6% |
| March 13, 2024 | 193.3% |
| March 12, 2024 | 210.8% |
| March 11, 2024 | 209.2% |
| March 08, 2024 | 190.1% |
| March 07, 2024 | 223.4% |
| March 06, 2024 | 194.7% |
| March 05, 2024 | 197.2% |
| March 04, 2024 | 204.2% |
| March 01, 2024 | 202.7% |
| February 29, 2024 | 206.8% |
| February 28, 2024 | 215.1% |
| February 27, 2024 | 211.6% |
| February 26, 2024 | 206.3% |
| February 23, 2024 | 212.0% |
| February 22, 2024 | 192.4% |
| February 21, 2024 | 200.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.78%
Minimum
Sep 27 2022
256.3%
Maximum
Jun 14 2023
-1.45%
Average
-24.65%
Median
1 Year Total Returns (Daily) Benchmarks
| Cyclacel Pharmaceuticals Inc | -69.72% |
| Arbutus Biopharma Corp | 6.75% |
| Oragenics Inc | -64.83% |
| Relmada Therapeutics Inc | 35.66% |
| MAIA Biotechnology Inc | 10.19% |